Clik here to view.
Asia’s supply chains to be tested by Covid-19 vaccine delivery
Steven Beck, head of trade finance at the ADB, explains how the logistical challenges of vaccine distribution will be aided by trade and supply chain finance guarantees Covid-19 vaccines […]
View ArticleClik here to view.
InSight: Building the necessary infrastructure for psychedelics
As psychedelic assets move from development to commercialisation over the next five to ten years, the thousands of therapists and clinics required to deliver these – and other psychedelic-assisted...
View ArticleClik here to view.
UK: Kyowa Kirin completes acquisition of Orchard Therapeutics
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has completed the acquisition of all outstanding shares in UK-based Orchard Therapeutics, a gene therapy developer. The integrated...
View ArticleClik here to view.
Switzerland: Bruker accelerates entry into lab automation with Chemspeed...
Nasdaq listed Bruker Corporation, a manufacturer of scientific instruments for molecular and materials research, is acquiring Chemspeed Technologies, a Swiss provider of vendor-agnostic automated...
View ArticleClik here to view.
France: StromaCare appoints Rawadi as CEO
StromaCare, a French biotechnology company pioneering the discovery and development of cancer immunotherapies through stroma modulation, has appointed Georges Rawadi as CEO. He brings over 20 years of...
View ArticleClik here to view.
UK: Ontario Teachers’ joins Nordic Capital as it reinvests in Advanz
Ontario Teachers’ Pension Plan Board, a leading global institutional investor, and healthcare investor, Nordic Capital, have agreed to jointly invest in Advanz Pharma, a UK-based global pharmaceutical...
View ArticleClik here to view.
UK: Aspire Pharma strengthens specialty pharma offering with acquisition of...
Aspire Pharma, a specialty generics business, has supplemented its organic growth with the acquisition of Cenoté Pharma, a category specialist in carnitine deficiencies. Financial terms were not...
View ArticleClik here to view.
US: Lonza increases large-scale biologics manufacturing capacity with US...
Lonza, a Switzerland-based global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has agreed to acquire the Genentech large-scale biologics manufacturing site in...
View ArticleClik here to view.
Italy: Stevanato ups and prices underwritten public offering
New York-listed Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has priced an upsized...
View ArticleClik here to view.
Germany: Novo Nordisk strengthens pipeline in cardiovascular disease with...
Novo Nordisk is to acquire Cardior Pharmaceuticals for up to €1.025bn (US$1.11bn), including an upfront payment and additional payments subject to certain development and commercial milestones being...
View ArticleClik here to view.
Cell & Gene Therapies: The next big opportunity in pharma services
Cell and Gene therapies are an exciting novel class of pharmaceuticals, and an area where pharma services including CDMOs are likely to play a significant role. Will Johnson, senior associate, […]
View ArticleClik here to view.
The Netherlands: Medios takes major step in building European Specialty...
Medios, a Germany-based company active in specialty pharmaceutical solutions, has acquired Ceban Pharmaceuticals, a fast-growing pharmaceutical compounding platform with operations in the Netherlands,...
View ArticleClik here to view.
France: Esteve Healthcare acquires Perrigo’s HRA Pharma Rare Diseases business
Esteve Healthcare, a Barcelona-headquartered global pharmaceutical company, is acquiring Perrigo’s HRA Pharma Rare Diseases business for up to €275m (US$296m), consisting of an upfront cash payment of...
View ArticleClik here to view.
UK: Mallon takes CEO seat at George Medicines
George Medicines, a late-stage, biopharmaceutical company addressing cardiometabolic disease, has appointed Mark Mallon as its new CEO. Mallon has a track record of leading the development and...
View ArticleClik here to view.
Switzerland: Novartis to acquire Mariana Oncology for up to US$1.75bn
Swiss-based multinational pharmaceutical company, Novartis, is acquiring Mariana Oncology, a US-based preclinical-stage biotechnology company focused on developing radioligand therapies (RLTs) to treat...
View ArticleClik here to view.
Austria: Novo Holdings to acquire majority stake in Single Use Support
Novo Holdings has agreed to acquire a majority stake in Single Use Support, a life science tools company providing advanced technology solutions for the pharmaceutical production process. The...
View ArticleClik here to view.
Singapore: AstraZeneca unveils plans to build ADC manufacturing facility
UK-based AstraZeneca, a global biopharmaceutical company, has announced plans to build a US$1.5bn manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global supply of its...
View ArticleClik here to view.
UK: Pheon completes US$120m Series B to fund ADC pipeline development
Pheon Therapeutics, an Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of hard-to-treat cancers, has completed a US$120m Series B financing to fund the...
View ArticleClik here to view.
Switzerland: SixPeaks Bio emerges from stealth with US$110m in fundinig
SixPeaks Bio has emerged from stealth with a pipeline of therapies for healthy weight loss and US$110m in funding. The company has secured US$30m in Series A financing led by […]
View ArticleClik here to view.
Switzerland: Johnson & Johnson to obtain rights to develop Numab’s NM26 for...
Numab Therapeutics, a clinical stage biotechnology company, is selling Yellow Jersey Therapeutics (YJT), a wholly-owned subsidiary of Numab, to US-based multinational Johnson & Johnson for...
View Article